On Demand Webinars

  1. RNA Vaccine Development To Phase I 4/14/2022

    Dr. John Lewis, Founder and CEO, Entos Pharmaceuticals, presents RNA Vaccine Development to Phase I.

  2. Accelerate Your pDNA And mRNA Process Development 11/13/2025

    Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.

  3. Development And Regulatory Strategy For US And China 9/22/2022

    This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers to Liver Cancers.

  4. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

    Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

  5. How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation 5/6/2024

    New technologies for the encapsulation of nucleic acids, such as FDmiX, can potentially overcome limitations of currently available standard mixing technologies.

  6. Best Practices In Aseptic Sampling To Improve Quality In Bioprocessing 5/30/2024

    Learn about the key aspects of aseptic sampling, appropriate methods and circumstances to perform sampling, and the impact a platform and sample containers can have on assay results and process dynamics.

  7. Evolving Into Biopharma 4.0: A Stepwise Journey Of Digital Transformation 8/29/2024

    You don’t need to make huge investments to shorten time-to-market. Watch to discover how incremental steps can transform your processes using digitalization and automation.

  8. Can A Small Plasmid Produce Huge Benefits? The Power Of Small 1/17/2023

    With benefits across applications, nanoplasmids are designed to replace antiquated bacterial backbones, while eliminating antibiotic markers that can cause regulatory concerns.

  9. Sustainable Vaccine Manufacturing: Securing The Future Of Global Health 7/22/2025

    Explore how next-gen technologies, from mRNA platforms to digital tools, are transforming vaccine manufacturing to make it more sustainable, flexible, and accessible.

  10. All Eyes On mRNA: Addressing Key Insights Into The Next Blockbuster

    With ongoing development efforts seeing infinite possibilities for cancers, autoimmune diseases, and genetic diseases, how should the industry apply this early victory into successful mRNA-based therapeutics and vaccines?